Achilles Therapeutics plc
ACHL · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $35,536 | $35,226 | $143,560 | $672,290 |
| - Cash | $131,539 | $173,338 | $266,319 | $177,849 |
| + Debt | $4,615 | $8,576 | $12,259 | $15,983 |
| Enterprise Value | -$91,388 | -$129,536 | -$110,500 | $510,424 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$4,731 | -$3,688 | -$3,288 | -$778 |
| % Margin | – | – | – | – |
| EBITDA | -$70,442 | -$67,333 | -$60,807 | -$32,955 |
| % Margin | – | – | – | – |
| Net Income | -$69,665 | -$71,176 | -$61,099 | -$33,199 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.74 | -1.82 | -2.13 | -0.82 |
| % Growth | 4.4% | 14.6% | -159.8% | – |
| Operating Cash Flow | -$48,449 | -$59,535 | -$59,284 | -$25,252 |
| Capital Expenditures | -$1,100 | -$7,512 | -$7,634 | -$11,847 |
| Free Cash Flow | -$49,549 | -$67,047 | -$66,918 | -$37,099 |